Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 15c, Updates FY EPS Guidance
August 6, 2020 7:00 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.63, $0.15 better than the analyst estimate of $1.48. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.97 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2020 EPS of $6.10-$6.25, versus the consensus of $6.20.... More
